Communicating uncertainties about prescription drugs to the public: A national randomized trial

Archives of Internal Medicine

Volumn 171, Issue 16, 2011, Pages 1463-1468

  Schwartz, Lisa M ^a,b   Woloshin, Steven ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONSUMER ATTITUDE; CONTROLLED STUDY; DRUG APPROVAL; DRUG INFORMATION; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HEARTBURN; HUMAN; INTERNET; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; UNCERTAINTY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; COMMUNICATION; CONSUMER PRODUCT SAFETY; DRUG APPROVAL; FEMALE; HEARTBURN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRESCRIPTION DRUGS; PROFESSIONAL-PATIENT RELATIONS; TREATMENT OUTCOME; UNCERTAINTY; YOUNG ADULT;

EID: 80052769095     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.396     Document Type: Article

References (17)

1. Baciu A, Stratto K, Burke SP; Committee on the Assessment of the US Drug Safety System. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: National Academies Press; 2006.
2. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17):2215-2220. (Pubitemid 34441937)
3. Kastelein JJ, Akdim F, Stroes ES, et al; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14):1431-1443. (Pubitemid 351482735)
4. Prescription drugs and mass media advertising. National Institute for Health Care Management Research and Educational Foundation Web site. http://nihcm.org/pdf/DTCbrief2001.pdf. Accessed March 30, 2011.
5. Direct-to-consumer advertising: analysis of DTC spend by brand, company and media: special report. www.pharmalive.com/special-reports/sample. cfmlp;&2p?reportID=276. Accessed June 26, 2011.
6. Baker LC, Bundorf MK, Singer S, Wagner TH. Validity of the Survey of Health and Internet and Knowledge Network's Panel and Sampling. Stanford, CA: Stanford University; 2003.
7. Chang L, Krosnick JA. National surveys via Rdd telephone interviewing versus the Internet: comparing sample representativeness and response quality. Public Opin Q. 2009;73(4):641-678.
8. Krotki K, Dennis JM. Probability-based survey research on the Internet: paper presented at the 53rd Conference of the International Statistical Institute; August 22-29, 2001; Seoul Korea. http://www.knowledgenetworks.com/ ganp/docs/ISI-2001-confernce-paper.pdf. Accessed March 8, 2011.
9. TESS: Time-sharing experiments for the social sciences. http://www.tessexperiments.org/. Accessed December 13, 2010.
10. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14(11):651-657.
11. Woloshin S, Schwartz L. Communicating data about the benefits and harms of treatment: a randomized trial. Ann Intern Med. 2011;155(18):87-96.
12. Current Population Survey (CPS). US Census Bureau Web site. http://www.census.gov/cps/. Accessed June 26, 2011.
13. Baker L,Wagner TH,Singer S, Bundorf MK. Use of the Internet and e-mail for health care information: results from a national survey. JAMA. 2003;289(18):2400-2406.
14. Black Triangle Scheme. Medicines and Healthcare Products Regulatory Agency Web site. http://www.mhra.gov.uk/Safetyinformation/ Reportingsafetyproblems/Reportingsuspectedadversedrugreactions/ Healthcareprofessionalreporting /BlackTriangleScheme/index.htm. Accessed June 26, 2011.
15. Schwartz LM, Woloshin S. Lost in transmission: a drug information that never reaches clinicians. N Engl J Med. 2009;361(18):1717-1720.
16. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150 (8):516-527.
17. Woloshin S, Schwartz LM. Bringing the FDA's information to market. Arch Intern Med. 2009;169(21):1985-1987.